This is the first evidence session of the inquiry.
The first panel contains a selection of science organisations with an interest in this area. The session will focus on the science of antimicrobial resistance, including why antimicrobial resistance has become so important, research avenues, the difference between clinical and other infection routes and questions surrounding the strategy.
Wednesday 18 December 2013, Thatcher Room, Portcullis House
- Dr Pat Goodwin, Scientific Consultant, Society of Biology
- Professor Laura Piddock, Professor of Microbiology, British Society for Antimicrobial Chemotherapy
- Professor John Threlfall, Member of Committee, Society for Applied Microbiology
- Professor Sharon Peacock, Cambridge Infectious Diseases Initiative, Professor of Clinical Microbiology, University of Cambridge
Further evidence sessions will be announced in due course.